View in EDS

OncoVEXmGM-CSFexpands tumor antigen-specific CD8+ T-cell response in preclinical models.

Saved in:
Bibliographic Details
Title: OncoVEXmGM-CSFexpands tumor antigen-specific CD8+ T-cell response in preclinical models.
Authors: Estrada J; Amgen Inc, Thousand Oaks, California, USA., Zhan J; Amgen Inc, Thousand Oaks, California, USA., Mitchell P; Amgen Inc, Thousand Oaks, California, USA., Werner J; Amgen Inc, Thousand Oaks, California, USA., Beltran PJ; BridgeBio Pharma, Palo Alto, California, USA., DeVoss J; Amgen Inc, Thousand Oaks, California, USA., Qing J; BeiGene, Beijing, China., Cooke KS; Amgen Inc, Thousand Oaks, California, USA kcooke@amgen.com.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2023 May; Vol. 11 (5).
Publication Type: Journal Article
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37164449
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: OncoVEX<superscript>mGM-CSF</superscript>expands tumor antigen-specific CD8+ T-cell response in preclinical models.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Estrada+J%22">Estrada J</searchLink>; Amgen Inc, Thousand Oaks, California, USA.<br /><searchLink fieldCode="AU" term="%22Zhan+J%22">Zhan J</searchLink>; Amgen Inc, Thousand Oaks, California, USA.<br /><searchLink fieldCode="AU" term="%22Mitchell+P%22">Mitchell P</searchLink>; Amgen Inc, Thousand Oaks, California, USA.<br /><searchLink fieldCode="AU" term="%22Werner+J%22">Werner J</searchLink>; Amgen Inc, Thousand Oaks, California, USA.<br /><searchLink fieldCode="AU" term="%22Beltran+PJ%22">Beltran PJ</searchLink>; BridgeBio Pharma, Palo Alto, California, USA.<br /><searchLink fieldCode="AU" term="%22DeVoss+J%22">DeVoss J</searchLink>; Amgen Inc, Thousand Oaks, California, USA.<br /><searchLink fieldCode="AU" term="%22Qing+J%22">Qing J</searchLink>; BeiGene, Beijing, China.<br /><searchLink fieldCode="AU" term="%22Cooke+KS%22">Cooke KS</searchLink>; Amgen Inc, Thousand Oaks, California, USA kcooke@amgen.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101620585%22">Journal for immunotherapy of cancer</searchLink> [J Immunother Cancer] 2023 May; Vol. 11 (5).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group+Ltd%22">BMJ Publishing Group Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101620585 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2051-1426 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220511426%22">20511426 </searchLink><i>NLM ISO Abbreviation: </i>J Immunother Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37164449
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1136/jitc-2022-006374
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: OncoVEXmGM-CSFexpands tumor antigen-specific CD8+ T-cell response in preclinical models.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Estrada J
      – PersonEntity:
          Name:
            NameFull: Zhan J
      – PersonEntity:
          Name:
            NameFull: Mitchell P
      – PersonEntity:
          Name:
            NameFull: Werner J
      – PersonEntity:
          Name:
            NameFull: Beltran PJ
      – PersonEntity:
          Name:
            NameFull: DeVoss J
      – PersonEntity:
          Name:
            NameFull: Qing J
      – PersonEntity:
          Name:
            NameFull: Cooke KS
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2023 May
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2051-1426
          Numbering:
            – Type: volume
              Value: 11
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Journal for immunotherapy of cancer
              Type: main
ResultId 1